Beemed Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 6 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -92.23%
- Profit Growth -6.74%
- Ebitda -204.68%
- Net Worth 95.22%
- Total Assets -90.49%
About Beemed Pharma Solutions
Beemed Pharma Solutions Private Limited (BPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2019 (Six years 3 days old ). Its registered office is in Dwarka, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sneh Leta and Devender Rana serve as directors at the Company.
Company Details
-
Location
Dwarka, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2019PTC345173
-
Company No.
345173
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2019
-
Date of AGM
25 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Beemed Pharma Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sneh Leta
|
Director | 03-Nov-2022 | Current |
|
Devender Rana
|
Director | 29-Jan-2019 | Current |
Financial Performance of Beemed Pharma Solutions.
Beemed Pharma Solutions Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 92.23% decrease. The company also saw a slight decrease in profitability, with a 6.74% decrease in profit. The company's net worth Soared by an impressive increase of 95.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Beemed Pharma Solutions?
In 2023, Beemed Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Carebridge Health Services Private LimitedSneh Leta is a mutual person
-
Cureboat Healthcare Private Limited
Sneh Leta is a mutual person
-
H2p Ecopower Private Limited
Devender Rana is a mutual person
-
Kladana Private Limited
Devender Rana is a mutual person
-
Wisdri Engineering & Research India Private Limited
Devender Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Beemed Pharma Solutions?
Beemed Pharma Solutions has a workforce of 16 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beemed Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beemed Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
